Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hirotaka Kamikozuru
ERCC1 Codon 118 Polymorphism Is a Useful Prognostic Marker in Patients With Pancreatic Cancer Treated With Platinum-Based Chemotherapy
International Journal of Oncology
Cancer Research
Oncology
Related publications
ERCC1 mRNA Expression Is Associated With the Clinical Outcome of Non-Small Cell Lung Cancer Treated With Platinum-Based Chemotherapy
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy
Oncotarget
Oncology
Pretreatment Systemic Inflammation Response Index in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
Cancer Management and Research
Oncology
Correlation of ERCC1 Expression in Peripheral Blood Lymphocytes With Outcomes of Patients With Gastric Cancer Treated With Oxaliplatin-Based Adjuvant Chemotherapy
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
TP53 Codon 72 Polymorphism Is Associated With Pancreatic Cancer Risk in Males, Smokers and Drinkers
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
The Addition of Postoperative Chemotherapy Is Associated With Improved Survival in Patients With Pancreatic Cancer Treated With Preoperative Therapy
Annals of Surgical Oncology
Oncology
Surgery
P53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab
Clinical Medicine Insights: Oncology
Oncology
Overexpression of Filamin-A Protein Is Associated With Aggressive Phenotype and Poor Survival Outcomes in NSCLC Patients Treated With Platinum-Based Combination Chemotherapy
Neoplasma
Cancer Research
